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ABSTRACT. The diastereoselective addition of an allylic indium intermediate to chiral o-
bromophenyl sulfinyl imine 4 proceeds with good levels of diastereoselectivity. The resulting 
homoallylic amine derivatives were transformed into lactams 7 and 12, which upon copper-
mediated intramolecular N-arylation leads to the formation of benzo-fused 1-
azabicyclo[m,n.o]alkanes 8 and 13. Benzo-fused 2-allyl substituted heterocycles 14 could also be 
prepared by means of a palladium-catalyzed N-arylation of the corresponding free amine. The 
synthesis of alkaloid (-)-angustureine was easily accomplished from (S)-2-allyltetrahydroquinoline 
14b.    
 
KEYWORDS. Chiral sulfinyl imines, diastereoselective addition, intramolecular N-arylation, 
indolizidine, quinolizidine, indoline, tetrahydroquinoline, benzazepine, (-)-angustureine. 
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INTRODUCTION 
Substituted benzo-fused 1-azabicyclo[m,n.o]alkanes with general structures I-VI (Figure 1) are 
embedded in numerous natural products and other biologically active compounds. Because of that, 
a rapid assembly of such molecules, in addition to the search for new molecular scaffolds represents 
a constant challenge to synthetic organic and medicinal chemists.  Thus, the development of new 
methodologies to access to these systems is of great interest. Related to the benzo-fused 
pyrrolizidine I is, for instance, (-)-isatisine A (1), a complex alkaloid isolated from the leaves of 
Isatis indigotica Fort,
1
 a herbaceous plant species used in Chinese folk medicine. One acetonide of 
(-)-isatisine A exhibits cytotoxycity against C8166 cells and anti-HIV activitiy. On the other hand, 
14,15-didehydro-10,11-dimethoxy-16-epivincamine (2),
2
 an alkaloid isolated from E. officinalis, E. 
divaricata, and E. divaricata Gouyahua plants of the Apocynaceae family, which have been applied 
in China as folklore herbs for the treatment of hypertension and sore throat, is an example of the 
benzo-fused indolizidine II (Figure 1). Structurally related to azabicycloalkane III is the 
pyridoacridine marine alkaloid arnoamine C (3),
3
 isolated from ascidians of the genus Cystodytes, 
which displays strong cytotoxic activity in different cell lines at low concentration (Figure 1). In 
addition, compounds bearing the 1-benzazepine moiety, a structural motif common to heterocycles 
of type V and VI, have achieved significant relevance as drugs, especially as antidepressants, for 
the treatment of neurodegenerative disorders and also in cardiovascular diseases. This class of 
compounds exhibit biological activity toward different targets, such as enzymes, ion channels and 
G-protein-coupled receptors (GPCRs).
4
 Different synthetic methodologies have been used to access 
to benzo-fused 1-azabicyclo[m,n.o]alkanes I-VI in both, a racemic or a enantioselective manner. 
For instance, the Schmidt reaction involving benzocycloalkyl carbocations and alkyl azides has 
been applied to the synthesis of heterocycles of the type I, III-V.
5
 The benzo-pyrrolizidine and -
indolizidine units, I and II, respectively, were also synthesized through a palladium(II)-catalyzed
6
  
or copper-promoted
7
 oxidative tandem cyclization using N-acryloyl- or –benzoyl o-allyl aromatic 
amines as substrates. The same type of heterocycles were prepared by means of a general catalytic 
protocol of non-carbonyl-stabilized rhodium carbenoid C-H insertions starting from N-aziridinyl 
imines
8
 and also using a selenium-based approach for a solid-phase synthesis.
9
 Tricycles of general 
structure I and III were obtained under palladium catalysis from chiral unsaturated amines taking 
place an intramolecular N-arylation reaction followed by an intermolecular alkene carboamination 
reaction.
10 
A recent reported methodology combining a regio- and stereoselective allylation and 
crotylation of indoles with potassium organotrifluoroborate salts with ring-closing metathesis 
allowed the synthesis in this case of compounds of type II.
11
 Iridium-catalyzed enantioselective 
hydrogenation of 2-substituted quinolines was used as the key step in the stereoselective synthesis 
of heterocyclic compounds III and IV.
12
 Enantioenriched benzo-fused indolizidines and 
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quinolizidines of type III and IV were also accessed via a catalytic asymmetric hydrogenation 
cascade using Hantzsch dihydropyridine as hydride donor and catalytic amounts of a chiral BINOL-
based phosphoric acid
13
 as well as through 7-endo-trig/ring contraction cascades involving 
phenonium ions, but in this last case in a racemic form.
14 
Regarding 1-benzazepines derivatives V 
and VI, many methodologies to synthesized these compounds are based on the expansion of smaller 
rings involving cationic and radical intermediates.
15
 More recently, palladium-catalyzed C-C and C-
N bond forming reactions have also been employed for the preparation of these compounds.
16 
On 
the other hand, we described the stereoselective allylation of N-tert-butylsulfinyl aldimines
17
 and 
ketimines
18
 with allylindium species, and the first one-pot α-aminoallylation of aldehydes with 
chiral tert-butanesulfinamide, allyl bromides, and indium, which provides homoallylic amines with 
high chemo- and stereoselectivities.
19 
It is worth mentioning that N-tert-butylsulfinyl derivatives
20
 
have found high applicability in synthesis as electrophiles because both enantiomers are accessible 
in large-scale processes
21
 and because the chiral auxiliary is easily removed under acidic conditions. 
In addition, practical processes for recycling the tert-butanesulfinyl group upon deprotection of N-
tert-butylsulfinyl amines have also been reported.
22
 Being aware of the importance of heterocycles 
of general structures I-VI with regard to biological activity and organic synthesis, we decided to 
applied the indium-promoted diastereoselective addition of allylic bromides to N-tert-butylsulfinyl 
aldimines bearing an o-bromophenyl unit, in combination with an intramolecular N-arylation, to 
develop new and flexible synthetic pathways to the target compounds of type I-VI. 
 
 
Figure 1. Basic Structures of Benzo-fused 1-Azabicyclo[m,n.o]alkanes and Representative Natural 
Products 
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RESULTS AND DISCUSSION 
We have already reported that the reaction of ethyl 2-(bromomethyl)acrylate (5) with different 
chiral N-sulfinyl aldimines in a saturated aqueous sodium bromide solution in the presence of 4 
equivalents of indium at room temperature for 48 hours proceeded with high diastereoselectivity to 
give rise to the corresponding amino ester derivative which could be easily transformed into an α-
methylene-γ-butyrolactam.
24
 When we applied these reaction conditions to chiral imines 4, amino 
esters 6 were obtained in reasonable yields and diastereoselectivities (Scheme 1). Diastereomeric 
ratio for compounds bearing the tert-butylsulfinyl unit was easily determined by 
1
H-NMR analysis 
of the crude reaction mixture through the comparison of the integrals of the t-Bu and the N–H 
groups for each diastereoisomer. On the other hand, yields given on Scheme 1 refer to isolated yield 
of the major diastereomer after column chromatography purification. The stereochemical pathway 
of the process is well known,
24
 the attack of the allylic indium intermediate occurring preferentially 
on the Re face of these imines with the S configuration at the sulfur atom. 
 
Scheme 1. Diastereoselective synthesis of amino ester derivatives 6 
 
 
Aminoester derivatives 6 were converted into butyrolactams 7 upon removal of the tert-
butylsulfinyl group by treatment first with a 4M HCl dioxane solution in methanol and then with 
sodium methoxide in methanol until basic pH. Good to excellent yields were achieved for 
compounds 7, the corresponding α-methylene-γ-butyrolactams being isolated in an almost 
enantiopure form (Scheme 2). 
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Scheme 2. Synthesis of α-methylene-γ-butyrolactams 7 from amino ester derivatives 6 
 
 
 
Then, we carried out an intramolecular N-arylation under Ullmann-type reaction conditions in 
compounds 7. For a model reaction, we optimized the cyclization of compound 7b using a simple 
catalyst system developed by Buchwald and co-workers: CuI, a diamine ligand and K2CO3 as 
base.
25
 All the reactions were performed at 100 ºC in the presence of 2 equivalents of K2CO3. 
Regarding the solvent, a higher conversion was achieved using dioxane instead of toluene (Table 1, 
compare entries 1 and 2). In all cases, copper(I) salt (CuI) and diamine [N,N’-
dimethylethyliedenediamine (DMEDA)] were in a 1:2 molar ratio, and 8 mol% was the optimal 
amount of copper(I) salt which led to a complete conversion (Table 1, entry 3).  
 
Table 1. Optimization of the intramolecular N-arylation of compound 7b 
 
Entry Reaction conditions Conversion (%)
a
 
1 
CuI (5 mol%), DMEDA (10 mol%), K2CO3 (2 equiv), PhMe, 110 °C, 
20 h 
28 
2 
CuI (5 mol%), DMEDA (10 mol%), K2CO3 (2 equiv), 1,4-dioxane, 
100 °C, 20 h 
50 
3 
CuI (8 mol%), DMEDA (16 mol%), K2CO3 (2 equiv), 1,4-dioxane, 
100 °C, 20 h 
100 
a
 Conversion is given based on the disappearance of the starting compound 7b by 
1
H-NMR. 
 
When we applied the optimized conditions depicted in Table 1, entry 3, to enantioenriched 
butyrolactams 7, pyrrolo-indoline (8a), -tetrahydroquinoline (8b) and tetrahydrobenzazepine (8c) 
Page 5 of 29
ACS Paragon Plus Environment
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
derivatives were obtained, although in the case of compound 8c, in a modest yield (Scheme 3). 
These compounds possess the pattern hydrocarbon skeleton of type I, III and V (Figure 1) and 
exhibit (S)-configuration at the stereogenic center. The corresponding enantiomers could be 
produced starting from the chiral aldimines 4 with (R)-configuration at the sulphur atom through the 
same synthetic pathway.  
 
Scheme 3. Synthesis of tricyclic compounds 8 from α-methylene-γ-butyrolactams 7 
 
 
In order to access to compounds with the pattern hydrocarbon skeleton of type II, IV and VI 
(Figure 1) we envisioned a different protocol where the allylation of chiral tert-butylsulfinyl imines 
1 was the first step of the synthesis. The allylation on imines 4 under standard conditions developed 
in our group, that is, treatment with allyl bromide in the presence of indium metal at 60 °C 
produced the homoallyl amine derivatives 9 in excellent yields and diastereoselectivities (Scheme 
4).
23
 The same reaction products were prepared in slightly lower yields and with almost identical 
diastereoselectivity performing an one-pot α-aminoallylation of the corresponding aldehyde with 
(S)-tert-butanesulfinamide and allyl bromide in the presence of indium metal and titanium 
tetraethoxide (Scheme 4).
19
  Column chromatography purification allowed access to compounds 9 
with high optical purity, the attack of allyl indium taking here also place on the Re face of these 
imines with the S configuration at the sulfur atom. 
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Scheme 4. Diastereoselective synthesis of homoallyl amine derivatives 9 
 
 
Removal of the tert-butylsulfinyl unit in homoallylamine derivatives 9 took place under acidic 
conditions giving rise to the free amines 10 in almost quantitative yields (Scheme 5). Treatment of 
amines 10 under Shotten-Baumann reaction conditions with acryloyl chloride at 0 ºC in a two-phase 
solvent system, consisting of 4M aqueous sodium hydroxide and dichloromethane, led to the 
formation of the targets acrylamide derivatives 11 in good yields (Scheme 5). It is important to 
perform the acylation at 0 ºC, because at higher temperatures, the 3-chloropropanamide derivative 
resulting from the conjugate addition of the anion chloride to the acrylamide is formed in a 
significant amount. In addition, column chromatography separation of acrylamides and 3-
chloropropanamides is not an easy task. Although these undesired reaction products do not interfere 
in the next step of the synthesis, this side reaction could be an important drawback by affecting the 
yield of the whole process.   
 
Scheme 5. Synthesis of acrylamides 11 from homoallyl amine derivatives 9 
 
Page 7 of 29
ACS Paragon Plus Environment
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Ring-closing metathesis (RCM) of acrylamides 11 by means a Hoveyda-Grubbs second generation 
ruthenium catalyst produced dihydropyridin-2-ones 12 in high yields in all cases (Scheme 6). Then, 
compounds 12 were treated under the optimized conditions depicted in Table 1, entry 3, to perform 
an intramolecular N-arylation, leading to the expected tricyclic compounds 13a and 13b in excellent 
yields. However, the reaction failed in the case of the pyrido-tetrahydrobenzazepine derivative 13c, 
the starting lactam 12c being recovered at the end of the reaction (Scheme 6). Pyrido-indoline (13a) 
and -tetrahydroquinoline (13b) derivatives possess the pattern hydrocarbon skeleton of type II and 
IV (Figure 1), but we could not access through this synthetic strategy to a member of the family 
type VI, like compound 13c.  
 
Scheme 6. Synthesis of tricyclic compounds 13 from dihydropyridin-2-ones 12 
 
 
Since the formation of the seven-membered ring through an Ullmann-intramolecular N-arylation 
from bromophenyl dihydropyridin-2-one derivative 12c failed, we planned to perform first an 
intramolecular N-arylation of the free amine 10c to synthesize the seven-membered ring of the 
benzazepine unit and after that the lactam ring. In order to find out the best reaction conditions for 
the intramolecular N-arylation, we took homoallyl amine derivative 10b as a model compound. As 
we expected, cyclization did not take place under the Ullmann-type reaction conditions depicted on 
Table 1, entry 3, which were found to be optimal for the lactam derivatives 7 and 12 (Table 2, entry 
1). We were please to find that 100% of conversion was achieved under palladium catalysis using 5 
mol% of Pd(OAc)2 and 7.5 mol% of (±)-BINAP, 2 equivalents of Cs2CO3 as base, in toluene at 100 
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ºC for 15 hours (Table 2, entry 2).
26
 Total conversion was also achieved under very similar reaction 
conditions, but using 15 mol% of PPh3 instead of the more expensive ligand (±)-BINAP (Table 2, 
entry 3). Unfortunately, decreasing the loading of Pd(OAc)2 from 5 mol% to 2 mol% led to a lower 
conversion (Table 2, entry 4).  
 
Table 2. Optimization of the intramolecular N-arylation of homoallylamine 10b 
 
Entry Reaction conditions Conversion (%)
a
 
1 
CuI (8 mol%), DMEDA (16 mol%), K2CO3 (2 equiv), 1,4-dioxane, 
100 °C, 20 h 
0 
2 
Pd(OAc)2 (5 mol%), (±)-BINAP (7.5 mol%), Cs2CO3 (2 equiv), 
PhMe, 110 °C, 15 h 
100 
3 
Pd(OAc)2 (5 mol%), PPh3 (15 mol%), Cs2CO3 (2 equiv), PhMe, 110 
°C, 21 h 
100 
4 
Pd(OAc)2 (2 mol%), PPh3 (6 mol%), Cs2CO3 (2 equiv), PhMe, 110 
°C, 24 h 
68 
a
 Conversion is given based on the disappearance of the starting 10b by 
1
H-NMR. 
 
Bicyclic compounds 14 were obtained when homoallylamine derivatives 10 were submitted to the 
reaction conditions shown in Table 2, entry 3. Purification of the reaction products was very easy by 
performing an acidic-basic work-up. Concerning the chemical efficiency of the cyclization 
regarding the size of the ring, 2-allylindoline (14a) was formed in lower yield than the 
tetrahydroquinoline (14b) and tetrahydrobenzazepine (14c) derivatives (Scheme 7).  
 
Scheme 7. Synthesis of 2-allylindoline 14a, -tetrahydroquinoline 14b and -tetrahydrobenzazepine 
14c from homoallylamines 10 
NH2
Br
( )
n Pd(OAc)2 (5%), PPh3 (15%), Cs2CO3 (2 equiv)
PhMe, 110 C, 21 h N
H
( )n
10 14
N
H
14a (68%)
N
H
14b (87%)
N
H
14c (84%)
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Fortunatelly, pyrido-tetrahydrobenzazepine derivative 13c was prepared in two steps from 
tetrahydrobenzazepine (14c): first N-acylation with acryloyl chloride in dichloromethane under 
anhydrous reaction conditions and subsequent RCM of the resulting acrylamide 15c using the 
Hoveyda-Grubbs second generation ruthenium catalyst (Scheme 8). Just for a comparative study 
regarding the effectiveness of both synthetic strategies to access to compounds 13, pyrido-
tetrahydroquinoline derivative 13b was also synthesized from 2-allyltetrahydroquinoline (14b) in 
two steps, being the yields a little bit higher than for 13c (Scheme 8). Thus, starting from common 
intermediate 10b, the overall yield is 52.3% in the process from 10b → 11b → 12b → 13b (lactam 
formation first followed by N-arylation), meanwhile the route 10b → 14b → 15b → 13b (first 
palladium catalyzed N-arylation and then formation of the lactam) was carried out in a 45.5% 
overall yield. The first strategy seems to be superior, although benzazepine derivative 13c could 
only be prepared following the second route. 
 
Scheme 8. Synthesis of tricyclic compounds 13b and 13c from 14b and 14c 
 
 
Compounds 8 and 13 are of interest not only because of their basic molecular architecture but also 
because the α,β-unsaturated lactam moiety allows further structural modifications, leading to more 
complex systems (Figure 2). In addition, the double bond of the allylic moiety in compounds 14 can 
participate in a number of further synthetically useful transformations: cross metathesis, 
epoxidation, oxidative cleavage, Heck type reaction, cycloaddition, hydroboration, 
hydroformylation, hydrogenation, hydration, ozonolysis, etc.
27
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Figure 2. Potential Application in Synthesis of Compounds 8, 13 and 14 
 
 
For instance, the synthetic utility of (S)-2-allyltetrahydroquinoline (14b) was exemplified in the 
synthesis of natural alkaloid (-)-angustureine (18) isolated from Galipea officinalis,
28
 a Venezuelan 
shrubby tree used in folk medicine as tonic in dyspepsia, dysentery, chronic diarrhea and also as 
antipyretic (Scheme 9).
29
 Tetrahydroquinoline derivative 14b was treated first with 
paraformaldehyde and NaBH3CN to give the 2-allyl-N-methyltetrahydroquinoline (16) in 95% 
yield, followed by a cross-metathesis with (Z)-hex-3-ene and final in situ hydrogenation of the 
resulting olefin 17 (Scheme 9). From compound 16, it was also possible to synthesize 
dehydrohomocuspareine 19, a compound related to tetrahydroquinoline alkaloid cuspareine, by 
performing a Heck-type reaction with 4-bromoveratrol (Scheme 9).  
 
Scheme 9. Synthesis of (-)-angustureine (18) from (S)-2-allyltetrahydroquinoline 14b 
N
H
N
Me
(HCHO)n, NaBH3CN
AcOH, MeCN, 23 ºC, 12 h
14b
N
Me
H2, Pd/C, MeOH
23 ºC, 12 h N
Me
(-)-angustureine (18, 54%)17
16 (95%)
Hoveyda-Grubbs cat.
CH2Cl2, 40 ºC, 2 h
Br OMe
OMe
Pd(PPh3)4 (5 mol%)
K2CO3 (2 equiv)
dioxane, 100 ºC, 24 h
N
Me
19 (40%)
OMe
OMe
 
 
In summary, benzo-fused 1-azabicyclo[m,n.o]alkanes 8 and 13, with general structures I-VI, and 2-
allylindoline, -tetrahydroquinoline and -tetrahydrobenzazepine 14, were easily accessible in high 
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optical purity from the imines derived from aliphatic aldehydes with a 2-bromophenyl substituent 
and (S)-tert-butanesulfinamide. The methodology presented here comprised as key steps a 
diastereoselective addition of an allylic indium intermediate to the chiral sulfinyl imine 4, and an 
intramolecular N-arylation, under Ullmann-type reaction conditions for lactams 7 and 12, or a 
palladium-mediated process in the case of the free amines 10. Functionalized tricyclic compounds 8 
and 13, as well as 2-allyl substituted heterocycles 14 could be used as building blocks for the 
synthesis of more complex molecules. As an example, natural alkaloid (-)-angustureine (18) was 
synthesized starting from (S)-2-allyltetrahydroquinoline 14b.  
 
 
EXPERIMENTAL SECTION 
General Remarks: (SS)-tert-Butanesulfinamide and its enantiomer were a gift of Medalchemy (> 
99% ee by chiral HPLC on a Chiracel AS column, 90:10 n-hexane/i-PrOH, 1.2 mL/min, λ=222 
nm). TLC was performed on silica gel 60 F254, using aluminum plates and visualized with 
phosphomolybdic acid (PMA) stain. Flash chromatography was carried out on handpacked columns 
of silica gel 60 (230- 400 mesh). Melting points are uncorrected. Optical rotations were measured 
using a polarimeter with a thermally jacketted 5 cm cell at approximately 20 ºC and concentrations 
(c) are given in g/100 mL. Infrared analyses were performed with a spectrophotometer equipped 
with an ATR component; wavenumbers are given in cm
-1
. Low-resolution mass spectra (EI) were 
obtained at 70 eV; and fragment ions in m/z with relative intensities (%) in parentheses. High-
resolution mass spectra (HRMS) were also carried out in the electron impact mode (EI) at 70 eV 
and on an apparatus equipped with a time of flight (TOF) analyzer and the samples were ionized by 
ESI techniques and introduced through an ultra-high pressure liquid chromatograph (UPLC) model. 
1
H NMR spectra were recorded at 300 or 400 MHz for 
1
H NMR and 75 or 100 MHz for 
13
C NMR, 
using CDCl3 as the solvent and TMS as internal standard (0.00 ppm). The data is being reported as: 
s = singlet, d = doublet, t = triplet, q = quatriplet, h = heptet, m = multiplet or unresolved, br s = 
broad signal, coupling constant(s) in Hz, integration. 
13
C NMR spectra were recorded with 
1
H-
decoupling at 100 MHz and referenced to CDCl3 at 77.16 ppm. DEPT-135 experiments were 
performed to assign CH, CH2 and CH3. Compound2 4a,
10
 4b
10
 and 4c
23
 were prepared from the 
corresponding o-bromophenyl aldehyde and  (SS)-tert-butanesulfinamide in THF in the presence of 
two equivalents of titanium tetraethoxide. 
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General procedure for the synthesis of amino ester derivatives 6:  
A mixture of the corresponding aldimine 4 (0.5 mmol), ethyl 2-(bromomethyl)acrylate (5, 0.128 g, 
0.65 mmol) and indium powder (0.226 g, 2.0 mmol) in a saturated aqueous NaBr solution (5 mL) 
was stirred for 48 h at 23 ºC. Then, the resulting mixture was hydrolyzed with water (10 mL), 
extrated with EtOAc (3 × 10 mL), dried over anhydrous MgSO4 and evaporated (15 Torr). The 
resulting residue was purified by column chromatography (silica gel, hexane/EtOAc) to yield pure 
products 6. Yields, physical and spectroscopic data follow. 
(4R,SS)-Ethyl N-(tert-butylsulfinyl)-4-amino-5-(2-bromophenyl)-2-methylenepentanoate (6a): 
The representative procedure was followed by using imine 4a (302 mg, 1 mmol). Purification by 
column chromatography (hexane/AcOEt, 2:1) yielded 6a (272 mg, 65%) as a colorless oil; [α]D
23
 
+2 (c 1.01, CH2Cl2); Rf 0.45 (AcOEt); IR ν (film) 3220, 1714, 1472, 1045 cm
−1
;  δH 7.52 (dd, J = 
8.0, 0.9 Hz, 1H), 7.25 (d, J = 7.6, 2.2 Hz, 1H), 7.22 (d, J = 7.6, 1.2 Hz, 1H), 7.07 (ddd, J = 8.0, 6.9, 
2.3 Hz, 1H), 6.35 (d, J = 1.3 Hz, 1H), 5.74 (d, J = 1.1 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 3.89-3.78 
(m, 1H), 3.60 (br d, J = 7.0 Hz, 1H), 2.96 (dd, J = 13.8, 5.7 Hz, 1H), 2.89 (dd, J = 13.8, 8.8 Hz, 
1H), 2.83 (dd, J = 14.0, 7.1 Hz, 1H), 2.64 (ddd, J = 14.1, 5.8, 0.6 Hz, 1H), 1.31 (t, J = 7.1 Hz, 3H), 
1.04 (s, 9H); δC 167.4 (C), 138.2 (C), 137.0 (C), 133.0 (CH), 132.0 (CH), 128.9 (CH2), 128.3 (CH), 
127.4 (CH), 125.2 (C), 61.2 (CH2), 56.7 (CH), 56.0 (C), 42.2 (CH2), 38.9 (CH2), 22.6 (CH3), 14.3 
(CH3); LRMS (EI) m/z 361 [M
+
 (
81
Br)-C4H8, 2%], 281 (16), 270 (21), 268 (18), 262 (15), 247 (73), 
245 (70), 208 (14), 207 (62), 191 (15), 190 (100), 184 (40), 182 (38), 174 (89), 172 (18), 171 (43), 
169 (45), 166 (27), 144 (22), 143 (15), 142 (96), 129 (11), 128 (35), 118 (31), 117 (24), 116 (21), 
115 (25), 112 (11), 100 (37), 96 (19), 91 (37), 90 (33), 89 (31), 87 (20), 69 (33), 63 (10), 59 (10); 
HRMS (EI): Calculated for C14H18
81
BrNO3S (M
+
-C4H8) 361.0170, found 361.0161. 
(4S,SS)-Ethyl N-(tert-butylsulfinyl)-4-amino-6-(2-bromophenyl)-2-methylenehexanoate (6b): 
The representative procedure was followed by using imine 4b (316 mg, 1 mmol). Purification by 
column chromatography (hexane/AcOEt, 2:1) yielded 6b (324 mg, 75%) as a colorless oil; [α]D
23
 
+40 (c 1.01, CH2Cl2); Rf 0.66 (AcOEt); IR ν (film) 3276, 1714, 1471, 1370, 1046 cm
−1
;  δH 7.52 
(dd, J = 8.0, 0.8 Hz, 1H), 7.19-7.26 (m, 2H), 7.06 (ddd, J = 8.1, 6.7, 2.4 Hz, 1H), 6.32 (d, J = 1.3 
Hz, 1H), 5.72 (d, J = 1.0 Hz, 1H), 4.21 (q, J = 7.1 Hz, 2H), 3.71 (br d, J = 6.4 Hz, 1H), 3.45-3.61 
(m, 1H), 2.91 (ddd, J = 13.5, 11.1, 5.0 Hz, 1H), 2.69-2.78 (m, 2H), 2.65 (dd, J = 14.2, 5.6 Hz, 1H), 
1.84 (ddd, J = 13.9, 10.8, 5.4 Hz, 1H), 1.66-1.77 (m, 1H), 1.30 (t, J = 7.1 Hz, 3H), 1.25 (s, 9H); δC 
167.5 (C), 141.2 (C), 137.1 (C), 132.9 (CH), 130.4 (CH), 128.6 (CH2), 127.8 (CH), 127.7 (CH), 
124.4 (C), 61.2 (CH2), 56.1 (C), 55.5 (CH), 38.7 (CH2), 35.9 (CH2), 32.6 (CH2), 22.9 (CH3), 14.27 
(CH3); LRMS (EI) m/z 375 [M
+
 (
81
Br)-C4H8, 2%], 294 (13), 261 (81), 260 (10), 259 (78), 197 (57), 
195 (57), 191 (13), 171 (100), 170 (10), 169 (100), 142 (11), 132 (43), 130 (11), 117 (53), 116 (12), 
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115 (28), 104 (10), 103 (11), 91 (14), 90 (20), 89 (13), 87 (25), 77 (16), 69 (13); HRMS (ESI): 
Calculated for C19H29
79
BrNO3S (M
+
+H) 430.1052, found 430.1054. 
(4S,SS)-Ethyl N-(tert-butylsulfinyl)-4-amino-7-(2-bromophenyl)-2-methyleneheptanoate (6c): 
The representative procedure was followed by using imine 4c (304 mg, 0.92 mmol). Purification by 
column chromatography (hexane/AcOEt, 2:1) yielded 6c (306 mg, 74%) as a colorless oil; [α]D
23
 
+39 (c 1.01, CH2Cl2); Rf 0.67 (AcOEt); IR ν (film) 3228, 2978, 1712, 1174, 1049, 751 cm
−1
;  δH 
7.52 (dd, J = 7.9, 1.1 Hz, 1H), 7.24-7.16 (m, 2H), 7.05 (ddd, J = 8.0, 6.9, 2.3 Hz, 1H), 6.30 (d, J = 
1.3 Hz, 1H), 5.69 (d, J = 1.1 Hz, 1H), 4.21 (q, J = 7.1 Hz, 2H), 3.60 (d, J = 5.9 Hz, 1H), 3.54-3.42 
(m, 1H), 2.72 (t, J = 7.6 Hz, 2H), 2.61 (br d, J = 6.2 Hz, 2H), 1.82-1.48 (m, 4H), 1.31 (t, J = 7.1 Hz, 
3H), 1.19 (s, 9H); δC 167.6 (C), 141.5 (C), 137.2 (C), 132.9 (CH), 130.4 (CH), 128.5 (CH2), 127.7 
(CH), 127.5 (CH), 124.5 (C), 61.2 (CH2), 55.9 (C), 55.2 (CH), 38.3 (CH2), 36.1 (CH2), 35.1 (CH2), 
25.9 (CH2), 22.9 (CH3), 14.3 (CH3); LRMS (EI) m/z 389 [M
+
 (
81
Br)-C4H8, 4%], 275 (35), 273 (36), 
211 (43), 209 (48), 207 (10), 187 (10), 174 (11), 171 (22), 169 (24), 146 (11), 132 (11), 131 (100), 
130 (16), 115 (23), 104 (19), 103 (11), 91 (21), 90 (12), 87 (18), 77 (12), 69 (13); HRMS (EI): 
Calculated for C16H22
81
BrNO3S (M
+
-C4H8) 387.0504, found 387.0490. 
 
General procedure for the synthesis of α-methylene-γ-butyrolactams 7:  
To a solution of the corresponding aminoester 6 (0.2 mmol) in MeOH (1 mL) was added a 4M HCl 
dioxane solution (0.5 mL) at 0 ºC. After 2 h stirring at the same temperature, a 2M NaOMe MeOH 
solution (2 mL) was added and the resulting mixture was stirred for 1 at 0 ºC. After that, it was 
hydrolyzed with water (10 mL), extrated with EtOAc (3 × 10 mL), dried over anhydrous MgSO4 
and evaporated (15 Torr). The resulting residue was purified by column chromatography (silica gel, 
hexane/EtOAc) to yield pure products 7. Yields, physical and spectroscopic data follow. 
(R)-5-(2-Bromobenzyl)-3-methylenepyrrolidin-2-one (7a): The representative procedure was 
followed by using amino ester derivative 6a (129 mg, 0.31 mmol). Purification by column 
chromatography (hexane/AcOEt, 1:1) yielded 7a (62 mg, 75%) as a colorless oil; [α]D
23
 -60 (c 0.85, 
CH2Cl2); Rf 0.57 (AcOEt); IR ν (film) 3210, 1694, 1658, 1439 cm
−1
;  δH 7.58 (dd, J = 7.9, 1.2 Hz, 
1H), 7.28 (dd, J = 7.3, 1.3 Hz, 1H), 7.21 (dd, J = 7.6, 2.0 Hz, 1H), 7.13 (ddd, J = 7.9, 7.2, 2.0 Hz, 
1H), 6.42 (br s, 1H), 6.01 (t, J = 2.7 Hz, 1H), 5.37 (t, J = 2.3 Hz, 1H), 4.08-3.99 (m, 1H), 3.04 (dd, J 
= 13.5, 5.8 Hz, 1H), 2.99 (ddt, J = 17.1, 7.8, 2.6 Hz, 1H), 2.86 (dd, J = 13.5, 8.0 Hz, 1H), 2.61 (ddt, 
J = 17.1, 4.0, 2.6 Hz, 1H); δC 170.2 (C), 138.9 (C), 136.7 (C), 133.4 (CH), 131.5 (CH), 128.9 (CH), 
127.9 (CH), 124.8 (C), 116.7 (CH2), 50.8 (CH), 43.5 (CH2), 32.9 (CH2); LRMS (EI) m/z 267 [M
+
 
(
81
Br), 1%], 96 (100), 53 (14); HRMS (ESI): Calculated for C12H13
79
BrNO (M
+
+H) 266.0181, 
found 266.0192. 
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(S)-5-(2-Bromophenylethyl)-3-methylenepyrrolidin-2-one (7b): The representative procedure 
was followed by using amino ester derivative 6b (202 mg, 0.47 mmol). Purification by column 
chromatography (hexane/AcOEt, 1:1) yielded 7b (124 mg, 94%) as a colorless oil; [α]D
23
 -25 (c 
0.91, CH2Cl2); Rf 0.46 (AcOEt); IR ν (film) 3203, 1693, 1658, 1299, 1022, 924 cm
−1
;  δH 7.53 (d, J 
= 7.8 Hz, 1H), 7.42 (br s, 1H), 7.26-7.21 (m, 1H), 7.12-7.03 (m, 1H), 5.99 (q, J = 2.4 Hz, 1H), 5.36 
(t, J = 2.3 Hz, 1H), 3.77-3.66 (m, 1H), 3.02 (ddt, J = 17.1, 7.8, 2.5 Hz, 1H), 2.80 (t, J = 8.0 Hz, 2H), 
2.54 (ddt, J = 17.2, 4.3, 2.7 Hz, 1H), 1.92-1.79 (m, 2H); δC 170.9 (C), 140.4 (C), 139.5 (C), 133.0 
(CH), 130.5 (CH), 128.1 (CH), 127.8 (CH), 124.4 (C), 116.2 (CH2), 51.0 (CH), 37.5 (CH2), 33.1 
(CH2), 32.4 (CH2); LRMS (EI) m/z 200 (M
+
-Br, 81%), 201 (14), 97 (10), 96 (100), 53 (15); HRMS 
(ESI): Calculated for C13H15
79
BrNO (M
+
+H) 280.0337, found 280.0333. 
(S)-5-(3-Bromophenylpropyl)-3-methylenepyrrolidin-2-one (7c): The representative procedure 
was followed by using amino ester derivative 6c (115 mg, 0.26 mmol). Purification by column 
chromatography (hexane/AcOEt, 1:1) yielded 7c (71 mg, 93%) as a white solid; mp 59-61 ºC 
(hexane/CH2Cl2); [α]D
23
 -17 (c 0.91, CH2Cl2); Rf 0.51 (AcOEt); IR ν (KBr) 3199, 1694, 1658, 1439, 
1291, 749 cm
−1
;  δH 7.53 (dd, J = 8.0, 0.9 Hz, 1H), 7.25-7.18 (m, 2H), 7.06 (ddd, J = 8.0, 6.9, 2.2 
Hz, 1H), 6.94 (br s, 1H), 5.97 (t, J = 2.8 Hz, 1H), 5.34 (s, 1H), 3.73-3.64 (m, 1H), 2.98 (dd, J = 
17.1, 7.8 Hz, 1H), 2.76 (t, J = 7.5 Hz, 2H), 2.45 (ddt, J = 17.1, 4.3, 2.7 Hz, 1H), 1.73-1.50 (m, 4H); 
δC 170.6 (C), 141.1 (C), 139.4 (C), 133.0 (CH), 130.5 (CH), 127.9 (CH), 127.6 (CH), 124.5 (C), 
116.2 (CH2), 51.2 (CH), 37.0 (CH2), 36.0 (CH2), 33.2 (CH2), 26.0 (CH2); LRMS (EI) m/z 295 [M
+
 
(
81
Br), 1%], 214 (59), 171 (5), 169 (5), 96 (100), 53 (12); HRMS (EI): Calculated for C14H16
81
BrNO 
295.0395, found 295.0390. 
 
General procedure for the synthesis of tricyclic compounds 8 from α-methylene-γ-
butyrolactams 7:  
A mixture of the corresponding α-methylene-γ-butyrolactams 7 (0.3 mmol), CuI (4.6 mg, 0.024 
mmol), K2CO3 (83 mg, 0.6 mmol) and N,N,N’,N’-tetrametiletilendiamina (5.6 mg, 7 µL, 0.048 
mmol) in dry dioxane (0.75 mL) was stirred at 100 ºC under Ar for 20 h in a high-pressure tube. 
Then, the resulting mixture was cooled down to room temperature and hydrolyzed with H2O (5 
mL), extracted with AcOEt (3 × 10 mL), dried over anhydrous MgSO4 and evaporated (15 Torr). 
The resulting residue was purified by column chromatography (silica gel, hexane/EtOAc) to yield 
pure products 8. Yields, physical and spectroscopic data follow. 
(S)-2-Methylene-9,9a-dihydro-1H-pyrrolo[1,2-a]indol-3(2H)-one (8a):
30
 The representative 
procedure was followed by using lactam 7a (42 mg, 0.16 mmol). Purification by column 
chromatography (hexane/AcOEt, 3:1) yielded 8a (15 mg, 52%) as a white solid; mp 76-78 ºC 
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(hexane/CH2Cl2); [α]D
23
 +285 (c 1.09, CH2Cl2); Rf 0.24 (hexane/AcOEt: 3/1); IR ν (KBr) 1686, 
1657, 1602, 1480, 1410, 757 cm
−1
;  δH 7.68 (d, J = 7.8 Hz, 1H), 7.26-7.19 (m, 2H), 7.07 (t, J = 7.5 
Hz, 1H), 6.07 (dd, J = 3.4, 1.6 Hz, 1H), 5.42 (dd, J = 2.9, 1.4 Hz, 1H), 4.65-4.55 (m, 1H), 3.21 (dd, 
15.7, 8.2 Hz, 1H), 3.17 (dd, 16.0, 6.8, 1.5 Hz, 2H), 2.90 (dd, J = 15.4, 10.7 Hz, 1H), 2.78-2.68 (m, 
1H); δC 164.4 (C), 143.7 (C), 139.7 (C), 134.1 (C), 128.0 (CH), 125.4 (CH), 124.8 (CH), 117.1 
(CH2), 115.2 (CH), 60.2 (CH), 36.3 (CH2), 34.2 (CH2); LRMS (EI) m/z 185 (M
+
, 100%), 186 (14), 
184 (18), 157 (16), 156 (32), 117 (42), 90 (14), 89 (16), 68 (14); HRMS (ESI): Calculated for 
C12H12NO (M
+
+H) 186.0919, found 186.0915. 
(S)-2-Methylene-3,3a,4,5-tetrahydropyrrolo[1,2-a]quinolin-1(2H)-one (8b): The representative 
procedure was followed by using lactam 7b (89 mg, 0.318 mmol). Purification by column 
chromatography (hexane/AcOEt, 4:1) yielded 8b (34 mg, 54%) as a white solid; mp 88-92 ºC 
(hexane/CH2Cl2); [α]D
23
 +150 (c 1.11, CH2Cl2); Rf 0.33 (hexane/AcOEt: 3/1); IR ν (KBr) 3062, 
2843, 1681, 1655, 1390, 905, 745 cm
−1
;  δH 8.71 (d, J = 8.3 Hz, 1H), 7.23 (t, J = 7.8 Hz, 1H), 7.14 
(d, J = 7.5 Hz, 1H), 7.05 (td, J = 7.5, 1.1 Hz, 1H), 6.10 (t, J = 2.8 Hz, 1H), 5.40 (t, J = 2.4 Hz, 1H), 
3.93-3.84 (m, 1H), 3.06 (ddt, J = 16.8, 7.6, 2.1 Hz, 1H), 3.01-2.94 (m, 1H), 2.93-2.85 (m, 1H), 2.49 
(ddt, J = 16.9, 6.3, 3.1 Hz, 1H), 2.23-2.16 (m, 1H), 1.75 (ddd, J = 25.0, 12.7, 5.6 Hz, 1H); δC 166.3 
(C), 139.6 (C), 136.8 (C), 129.3 (CH), 126.9 (CH), 126.3 (C), 124.1 (CH), 120.0 (CH), 116.5 
(CH2), 54.7 (CH), 31.4 (CH2), 29.6 (CH2), 27.7 (CH2); LRMS (EI) m/z 199 (M
+
, 100%), 200 (14), 
198 (43), 170 (39), 131 (24), 130 (26); HRMS (EI): Calculated for C13H13NO 199.0997, found 
199.0983. 
(S)-2-Methylene-2,3,3a,4,5,6-hexahydro-1H-benzo[f]pyrrolo[1,2-a]azepin-1-one (8c): The 
representative procedure was followed by using lactam 7c (67 mg, 0.228 mmol). Purification by 
column chromatography (hexane/AcOEt, 3:1) yielded 8c (13 mg, 27%) as a white solid; mp 101-
103 ºC (hexane/CH2Cl2); [α]D
23
 -31 (c 1.03, CH2Cl2); Rf 0.17 (hexane/AcOEt: 3/1); IR ν (KBr) 
2931, 1689, 1659, 1494, 1402 cm
−1
;  δH 7.35 (dd, J = 7.5, 1.1 Hz, 1H), 7.29-7.14 (m, 3H), 6.13 (t, J 
= 2.8 Hz, 1H), 5.45 (ddd, J = 2.6, 1.7, 0.7 Hz, 1H), 3.63-3.53 (m, 1H), 3.16 (ddt, J = 16.7, 8.7, 3.3 
Hz, 1H), 2.83-2.66 (m, 2H), 2.51 (ddd, J = 16.8, 3.6, 1.8 Hz, 1H), 2.08-1.94 (m, 2H), 1.74-1.55 (m, 
1H), 1.54-1.36 (m, 1H); δC 167.5 (C), 139.4 (C), 139.3 (C), 138.7 (C), 130.3 (CH), 127.4 (CH), 
127.2 (CH), 127.1 (CH), 117.0 (CH2), 58.3 (CH), 39.5 (CH2), 35.2 (CH2), 33.8 (CH2), 25.8 (CH2); 
LRMS (EI) m/z 213 (M
+
, 100%), 214 (15), 212 (45), 198 (14), 185 (11), 184 (33), 156 (15), 145 
(10), 144 (18), 117 (23), 68 (10); HRMS (EI): Calculated for C14H16NO 214.1232, found 214.1223. 
 
General procedure for the synthesis of homoallyl amine derivatives 9 from imines 4: 
A mixture of the corresponding N-tertbutylsulfinyl imine 4 (1.0 mmol), allyl bromide (166 mg, 
0.132 mL, 1.5 mmol), and indium (144 mg, 1.25 mmol) in dry THF (3 mL) was stirred for 6 h at 60 
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°C. Then, the resulting mixture was hydrolyzed with H2O (5 mL), and the solution was extracted 
with AcOEt (3 × 5 mL). The combined organic phases were washed with brine (3 × 10 mL), dried 
with anhydrous MgSO4, and evaporated (15 Torr). The residue was purified by column 
chromatography (silica gel, hexane/AcOEt) to yield products 9. Yields, physical and spectroscopic 
data follow. 
(2R,SS)-1-(2-Bromophenyl)-N-(tert-butylsulfinyl)pent-4-en-2-amine (9a):
23
 The representative 
procedure was followed by using imine 4a (453 mg, 1.5 mmol). Purification by column 
chromatography (hexane/AcOEt, 3:1) yielded 9a (378 mg, 73%) as a yellow solid; mp 42-45 ºC 
(hexane/CH2Cl2); [α]D
23
 +9 (c 1.08, CH2Cl2); Rf 0.32 (hexane/AcOEt: 1/1); IR ν (KBr) 3216, 1736, 
1472, 1045, 1024, 912, 749 cm
−1
;  δH 7.53 (d, J = 8.5 Hz, 1H), 7.21-7.25 (m, 2H), 7.03-7.11 (m, 
1H), 5.79-5.93 (m, 1H), 5.18-5.25 (m, 2H), 3.63-3.72 (m, 1H), 3.34 (br d, J = 6.9 Hz, 1H), 2.95 (dd, 
J = 7.2, 5.5 Hz, 2H), 2.48 (t, J = 6.7 Hz, 2H), 1.06 (s, 9H); δC 138.3 (C), 133.9 (CH), 133.0 (CH), 
132.0 (CH), 128.3 (CH), 127.4 (CH), 125.2 (C), 119.5 (CH2), 56.2 (CH), 56.0 (C), 41.8 (CH2), 40.7 
(CH2), 22.6 (CH3); LRMS (EI) m/z 247 (3), 245 (3), 208 (9), 184 (8), 182 (8), 171 (11), 169 (11), 
118 (100), 91 (11), 90 (11), 89 (10). 
(3S,SS)-1-(2-Bromophenyl)-N-(tert-butylsulfinyl)hex-5-en-3-amine (9b):
23
 The representative 
procedure was followed by using imine 4b (221 mg, 0.70 mmol). Purification by column 
chromatography (hexane/AcOEt, 3:1) yielded 9b (202 mg, 81%) as a colorless oil; [α]D
23
 +43 (c 
0.95, CH2Cl2); Rf 0.34 (hexane/AcOEt: 1/1); IR ν (film) 3215, 1471, 1439, 1052, 1022, 749 cm
−1
;  
δH 7.52 (d, J = 7.9 Hz, 1H), 7.19-7.26 (m, 2H), 7.03-7.09 (m, 1H), 5.75-5.87 (m, 1H), 5.15-5.22 (m, 
2H), 3.37-3.46 (m, 1H), 3.33 (br d, J = 6.6 Hz, 1H), 2.89 (ddd, J = 13.5, 11.1, 5.1 Hz, 1H), 2.73 
(ddd, J = 13.5, 11.1, 5.7 Hz, 1H), 2.39-2.55 (m, 2H), 1.70-1.91 (m, 2H), 1.25 (s, 9H); δC 141.3 
(ArC), 134.0 (CH), 133.0 (CH), 130.4 (CH), 127.9 (CH), 127.7 (CH), 124.5 (ArC), 119.4 (CH2), 
56.1 (C), 55.1 (CH), 40.7 (CH2), 35.5 (CH2), 32.7 (CH2), 22.9 (CH3); LRMS (EI) m/z 261 (29), 259 
(29), 222 (46), 197 (37), 195 (37), 172 (16), 171 (97), 169 (100), 132 (39), 118 (23), 117 (49), 115 
(10), 104 (12), 103 (14), 102 (15), 91 (24), 90 (28), 89 (17), 77 (26), 70 (21). 
(4S,SS)-7-(2-Bromophenyl)-N-(tert-butylsulfinyl)hept-1-en-4-amine (9c):
23 
The representative 
procedure was followed by using imine 4c (300 mg, 0.91 mmol). Purification by column 
chromatography (hexane/AcOEt, 3:1) yielded 9c (318 mg, 94%) as a colorless oil; [α]D
23
 +40 (c 
1.06, CH2Cl2); Rf 0.44 (hexane/AcOEt: 1/1); IR ν (film) 3217, 1471, 913, 750 cm
−1
;  δH 7.50-7.56 
(m, 1H), 7.16-7.26 (m, 2H), 7.01-7.10 (m, 1H), 5.70-5.86 (m, 1H), 5.11-5.20 (m, 2H), 3.31-3.41 (m, 
1H), 3.22 (br d, J = 6.0 Hz, 1H), 2.72 (t, J = 7.6 Hz, 2H),2.38-2.46 (m, 1H), 2.27-2.37 (m, 1H), 
1.51-1.8 (m, 4H), 1.20 (s, 9H); δC 141.5 (C), 134.2 (CH), 132.9 (CH), 130.4 (CH), 127.7 (CH), 
127.5 (CH), 124.5 (C), 119.1 (CH2), 55.9 (C), 54.7 (CH), 40.5 (CH2), 36.2 (CH2), 34.7 (CH2), 25.9 
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(CH2), 22.8 (CH3); LRMS (EI) m/z 317 (20), 315 (19), 275 (11), 273 (11), 224 (10), 211 (29), 209 
(30), 171 (25), 169 (25), 146 (12), 132 (11), 131 (100), 130 (18), 118 (24), 115 (16), 104 (29), 103 
(18), 102 (15), 91 (40), 90 (21), 89 (16), 77 (25), 70 (14), 56 (15), 55 (10). 
 
General procedure for the synthesis of homoallyl amine derivatives 9 from 2-bromophenyl 
aldehydes:  
A mixture of indium powder (173 mg, 1.50 mmol), (S)-tert-butanesulfinamide (121 mg, 1.00 
mmol), the corresponding 2-bromophenyl aldehyde (1.15 mmol), and Ti(OEt)4 (456 mg, 0.450 mL, 
2.00 mmol) in THF (2 mL) was stirred under Ar for 1 h at 23 ºC. At this time, allyl bromide (166 
mg, 0.132 mL, 1.5 mmol) was added and the reaction mixture heated for 5 h at 60 ºC. The mixture 
was allowed to cool to room temperature, quenched with brine (2 mL), and diluted with EtOAc. 
The resulting suspension was filtered through a short pad of Celite and concentrated in vacuo (15 
Torr). The residue was purified by column chromatography (silica gel, hexane/AcOEt) to yield 
products 9. Yields follow. 
(2R,SS)-1-(2-Bromophenyl)-N-(tert-butylsulfinyl)pent-4-en-2-amine (9a):
23
 The representative 
procedure was followed by using imine (2-bromophenyl)acetaldehyde (995 mg, 5.0 mmol). 
Purification by column chromatography (hexane/AcOEt, 3:1) yielded 9a (1.07 g, 62%) as a yellow 
solid. 
(3S,SS)-1-(2-Bromophenyl)-N-(tert-butylsulfinyl)hex-5-en-3-amine (9b):
23
 The representative 
procedure was followed by using 3-(2-bromophenyl)propanal (782 mg, 3.67 mmol). Purification by 
column chromatography (hexane/AcOEt, 3:1) yielded 9b (1.04 g, 80%) as a colorless oil. 
(4S,SS)-7-(2-Bromophenyl)-N-(tert-butylsulfinyl)hept-1-en-4-amine (9c):
23 
The representative 
procedure was followed by using 4-(2-bromophenyl)butanal (1.16 g, 5.11 mmol). Purification by 
column chromatography (hexane/AcOEt, 3:1) yielded 9c (1.51 g, 80%) as a colorless oil. 
 
General procedure for the synthesis of homoallyl amines 10 from homoallyl amine derivatives 
9:  
To a solution of the corresponding homoallyl amide derivative 9 (0.5 mmol) in dry THF (1 mL) at 0 
ºC was added HCl (6M solution, 0.25 mL, 1.5 mmol). The reaction mixture was stirred at room 
temperature for 1 h. Then, it was cooled down to 0 ºC and NaOH (4M solution, 1 mL, 4 mmol) was 
added. The mixture was diluted with AcOEt (10 mL). The aqueous phase was extracted with AcOEt 
(2 × 10 mL). Then, the organic phases were washed with H2O (10 mL), dried with anhydrous 
MgSO4 and evaporated (15 Torr) to yield free amines 10. Yields, physical and spectroscopic data 
follow. 
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(R)-1-(2-Bromophenyl)pent-4-en-2-amine (10a): The representative procedure was followed by 
using sulfinamide 9a (688 mg, 2.0 mmol). Removal of the solvents at low pressure yielded 10a 
(475 mg, 97%) as a yellow oil; [α]D
23
 -10 (c 1.11, CH2Cl2); Rf 0.41 (CH2Cl2/MeOH: 9/1); IR ν 
(film) 2923, 2856, 1470, 1438 cm
−1
;  δH 7.55 (d, J = 7.8 Hz, 1H), 7.26-7.22 (m, 2H), 7.12-7.05 (m, 
1H), 5.84 (dddd, J = 16.8, 10.2, 7.9, 6.4 Hz, 1H), 5.20-5.08 (m, 2H), 3.19 (tt, J = 8.2, 4.9 Hz, 1H), 
2.95 (dd, J = 13.4, 5.0 Hz, 1H), 2.64 (dd, J = 13.4, 8.4 Hz, 1H), 2.31 (dddt, J = 13.8, 6.3, 4.7, 1.4 
Hz, 1H), 2.18-2.05 (m, 1H), 1.47 (br s, 2H); δC 139.1 (C), 135.6 (CH), 133.1 (CH), 131.7 (CH), 
128.1 (CH), 127.4 (CH), 125.0 (C), 117.9 (CH2), 50.6 (CH), 44.3 (CH2), 42.1 (CH2); LRMS (EI) 
m/z 200 [M
+
 (
81
Br)-C3H5, 22%], 198 (22), 119 (16), 118 (11), 91 (11), 70 (100); HRMS (ESI): 
Calculated for C11H15
79
BrN (M
+
+H) 240.0388, found 240.0379. 
(S)-1-(2-Bromophenyl)hex-5-en-3-amine (10b): The representative procedure was followed by 
using sulfinamide 9b (573 mg, 1.50 mmol). Removal of the solvents at low pressure yielded 10b 
(380 mg, 100%) as a colorless oil; [α]D
23
 -7 (c 1.16, CH2Cl2); Rf 0.37 (CH2Cl2/MeOH: 9/1); IR ν 
(film) 2917, 1470, 1438, 1022, 913, 747 cm
−1
;  δH 7.52 (d, J = 7.8 Hz, 1H), 7.24-7.21 (m, 2H), 
7.11-7.00 (m, 1H), 5.89-5.73 (m, 1H), 5.16-5.11 (m, 1H), 5.10-5.08 (m, 1H), 2.93-2.71 (m, 3H), 
2.36-2.25 (m, 1H), 2.12-1.97 (m, 1H), 1.75 (dddd, J = 13.5, 10.8, 5.9, 5.0 Hz, 1H), 1.66-1.53 (m, 
1H), 1.46 (br d, J = 0.8 Hz, 2H); δC 141.7 (C), 135.7 (CH), 132.9 (CH), 130.4 (CH), 127.7 (CH), 
127.6 (CH), 124.5 (C), 117.7 (CH2), 50.5 (CH), 42.7 (CH2), 38.0 (CH2), 33.1 (CH2); LRMS (EI) 
m/z 214 [M
+
 (
81
Br)-C3H5, 98%], 213 (12), 212 (100), 197 (8), 195 (8), 171 (77), 169 (78), 90 (13), 
70 (19); HRMS (ESI): Calculated for C12H17
79
BrN (M
+
+H) 254.0544, found 254.0537. 
(S)-7-(2-Bromophenyl)hept-1-en-4-amine (10c):
 
The representative procedure was followed by 
using sulfinamide 9c (502 mg, 1.35 mmol). Removal of the solvents at low pressure yielded 10c 
(357 mg, 99%) as a colorless oil; [α]D
23
 -4 (c 1.01, CH2Cl2); Rf 0.34 (CH2Cl2/MeOH: 9/1); IR ν 
(film) 2925, 1470, 1437, 1022, 913 cm
−1
;  δH 7.53-7.50 (m, 1H), 7.23-7.20 (m, 2H), 7.08-7.01 (m, 
1H), 5.85-5.73 (m, 1H), 5.12-5.06 (m, 2H), 2.88-2.79 (m, 1H), 2.79-2.67 (m, 2H), 2.30-2.20 (m, 
1H), 2.06-1.94 (m, 1H), 1.79-1.58 (m, 2H), 1.57-1.34 (m, 4H); δC 141.8 (C), 135.8 (CH), 132.9 
(CH), 130.4 (CH), 127.6 (CH), 127.5 (CH), 124.5 (C), 117.5 (CH2), 50.5 (CH), 42.6 (CH2), 37.3 
(CH2), 36.3 (CH2), 26.7 (CH2); LRMS (EI) m/z 214 [M
+
 (
81
Br)-C3H5, 99%], 227 (12), 226 (100), 
169 (11), 130 (39), 129 (12), 104 (14), 70 (23), 56 (12); HRMS (ESI): Calculated for C13H19
79
BrN 
(M
+
+H) 268.0701, found 268.0691. 
 
General procedure for the synthesis of acrylamides 11 from homoallyl amine derivatives 9:  
To a solution of the corresponding homoallyl amide derivative 9 (0.5 mmol) in dry THF (1 mL) at 0 
ºC was added HCl (6M solution, 0.25 mL, 1.5 mmol). The reaction mixture was stirred at room 
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temperature for 1 h. Then, it was cooled down to 0 ºC and NaOH (4M solution, 1 mL, 4 mmol) was 
added, and after 5 min, CH2Cl2 (1.5 mL) and acryloyl chloride (54 mg, 51 µL, 0.6 mmol) were also 
added. The resulting reaction mixture was stirred for 30 minutes at room temperature and after that 
it was diluted with AcOEt (15 mL). The aqueous phase was extracted with AcOEt (2 × 15 mL). 
Then, the organic phases were washed with H2O (10 mL), dried with anhydrous MgSO4 and 
evaporated (15 Torr). The residue was purified by column chromatography (silica gel, 
hexane/AcOEt) to yield products 11. Yields, physical and spectroscopic data follow. 
(R)-N-Acryloyl-1-(2-bromophenyl)pent-4-en-2-amine (11a): The representative procedure was 
followed by using sulfinamide 9a (473 mg, 1.38 mmol). Purification by column chromatography 
(hexane/AcOEt, 3:1) yielded 11a (281 mg, 69%) as a white solid; mp 81-83 ºC (hexane/CH2Cl2); 
[α]D
23
 -18 (c 1.04, CH2Cl2); Rf 0.56 (hexane/AcOEt: 1/1); IR ν (KBr) 3215, 1471, 1439, 1052, 
1022, 749 cm
−1
;  δH 7.52 (dd, J = 7.9, 1.0 Hz, 1H), 7.29-7.19 (m, 2H), 7.06 (ddd, J = 8.0, 6.9, 2.2 
Hz, 1H), 6.19 (dd, J = 17.0, 1.6 Hz, 1H), 6.02 (dd, J = 17.0, 10.1 Hz, 1H), 5.92-5.73 (m, 1H), 5.76 
(br d, J = 6.7 Hz, 1H), 5.57 (dd, J = 10.1, 1.6 Hz, 1H), 5.17-5.07 (m, 2H), 4.47-4.33 (m, 1H), 2.99 
(d, J = 7.2 Hz, 1H), 2.45-2.26 (m, 2H); δC 165.2 (C), 137.9 (C), 134.2 (CH), 132.9 (CH), 131.3 
(CH), 131.1 (CH),  128.3 (CH), 127.7 (CH), 126.3 (CH2), 125.0 (C), 118.4 (CH2), 49.9 (CH), 39.9 
(CH2), 38.8 (CH2); LRMS (EI) m/z 295 [M
+
 (
81
Br), 2%], 254 (29), 252 (29), 214 (10), 200 (33), 198 
(34), 124 (100), 91 (10), 90 (11), 89 (10), 70 (53), 55 (46); HRMS (ESI): Calculated for 
C14H17
79
BrNO (M
+
+H) 294.0494, found 294.0485.  
(S)-N-Acryloyl-1-(2-bromophenyl)hex-5-en-3-amine (11b): The representative procedure was 
followed by using sulfinamide 9b (179 mg, 0.50 mmol). Purification by column chromatography 
(hexane/AcOEt, 3:1) yielded 11b (230 mg, 84%) as a white solid; mp 50-53 ºC (hexane/CH2Cl2);  
[α]D
23
 +17 (c 1.05, CH2Cl2); Rf 0.56 (hexane/AcOEt: 1/1); IR ν (KBr) 3271, 1654, 1626, 1543, 
1438 cm
−1
;  δH 7.51 (d, J = 7.8 Hz, 1H), 7.25-7.20 (m, 2H), 7.10-7.00 (m, 1H), 6.29 (dd, J = 17.0, 
1.6 Hz, 1H), 6.11 (dd, J = 17.0, 10.1 Hz, 1H), 5.88-5.71 (m, 1H), 5.64 (dd, J = 10.1, 1.6 Hz, 1H), 
5.59 (br d, J = 8.8 Hz, 1H), 5.15-5.04 (m, 2H), 4.19 (m, 1H), 2.88-2.67 (m, 2H), 2.42-2.22 (m, 2H), 
1.87 (dddd, J = 10.4, 6.2, 5.5, 3.7 Hz, 1H), 1.79-1.62 (m, 1H); δC 165.3 (C), 141.0 (C), 134.1 (CH), 
132.9 (CH), 131.2 (CH), 130.6 (CH), 127.9 (CH), 127.7 (CH), 126.5 (CH2), 124.3 (C), 118.3 (CH2), 
48.7 (CH), 39.3 (CH2), 34.8 (CH2), 33.0 (CH2); LRMS (EI) m/z 309 [M
+
 (
81
Br), 2%], 307 (2), 269 
(11), 268 (85), 267 (12), 266 (86), 215 (10), 214 (97), 213 (11), 212 (100), 197 (24), 195 (25), 171 
(43), 169 (45), 132 (16), 125 (13), 116 (12), 115 (11), 90 (14), 89 (10), 84 (10), 77 (13), 72 (28), 7 
(16), 55 (69); HRMS (ESI): Calculated for C15H19
79
BrNO (M
+
+H) 308.0650, found 308.0638.  
(S)-N-Acryloyl-7-(2-bromophenyl)hept-1-en-4-amine (11c):
 
The representative procedure was 
followed by using sulfinamide 9c (155 mg, 0.42 mmol). Purification by column chromatography 
(hexane/AcOEt, 3:1) yielded 11c (111 mg, 83%) as a white solid; mp 73-75 ºC (hexane/CH2Cl2); 
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[α]D
23
 -2.5 (c 1.02, CH2Cl2); Rf 0.57 (hexane/AcOEt: 1/1); IR ν (KBr) 3273, 2941, 1653, 1625, 
1545, 748 cm
−1
;  δH 7.51 (d, J = 8.0 Hz, 1H), 7.23-7.16 (m, 2H), 7.04 (ddd, J = 8.0, 6.4, 2.7 Hz, 
1H), 6.26 (dd, J = 16.9, 1.6 Hz, 1H), 6.07 (dd, J = 16.9, 10.2 Hz, 1H), 5.85-5.68 (m, 1H), 5.62 (dd, 
J = 10.2, 1.6 Hz, 1H), 5.45 (br d, J = 9.0 Hz, 1H), 5.13-5.02 (m, 2H), 4.22-4.07 (m, 1H), 2.82-2.65 
(m, 2H), 2.37-2.16 (m, 2H), 1.75-1.39 (m, 4H); δC 165.2 (C), 141.5 (C), 134.2 (CH), 132.9 (CH), 
131.2 (CH), 130.5 (CH), 127.7 (CH), 127.5 (CH), 126.4 (CH2), 124.5 (C), 118.2 (CH2), 48.5 (CH), 
39.2 (CH2), 36.0 (CH2), 34.1 (CH2), 26.4 (CH2); LRMS (EI) m/z 323 [M
+
 (
81
Br), 1%], 282 (32), 280 
(32), 228 (77), 226 (79), 211 (40), 209 (41), 171 (20), 169 (15), 152 (13), 130 (19), 129 (11), 124 
(10), 91 (11), 90 (12), 72 (52), 70 (26), 56 (13), 55 (100); HRMS (ESI): Calculated for 
C16H21
79
BrNO (M
+
+H) 322.0807, found 322.0811. 
 
General procedure for the synthesis of pyridine-2-ones 12 from acrylamides 11:  
A mixture of the corresponding acrylamide 11 (0.75 mmol), ruthenium Hoveyda-Grubbs catalyst 
(19 mg, 0.0225 mmol) in dry CH2Cl2 (7.5 mL) was stirred at 40 ºC under Ar for 3 h. Then the 
solvent was evaporated (15 Torr) and the resulting residue was purified by column chromatography 
(silica gel, hexane/AcOEt) to yield products 12. Yields, physical and spectroscopic data follow. 
(R)-6-(2-Bromobenzyl)-5,6-dihydropyridin-2(1H)-one (12a): The representative procedure was 
followed by using acrylamide 11a (221 mg, 0.75 mmol). Purification by column chromatography 
(hexane/AcOEt, 3:2) yielded 12a (164 mg, 82%) as a white solid; mp 69-72 ºC (hexane/CH2Cl2); 
[α]D
23
 -13 (c 1.02, CH2Cl2); Rf 0.47 (AcOEt); IR ν (KBr) 3220, 1672, 1609, 1470, 1426 cm
−1
;  δH 
7.57 (dd, J = 8.0, 1.2 Hz, 1H), 7.28 (td, J = 7.4, 1.2 Hz, 1H), 7.21 (dd, J = 7.6, 1.7 Hz, 1H), 7.14 (td, 
J = 7.9, 1.8 Hz, 1H), 6.61 (ddd, J = 9.9, 4.9, 3.5 Hz, 1H), 5.94 (ddd, J = 9.9, 3.6, 2.0 Hz, 1H), 5.68 
(br s, 1H), 4.00-3.91 (m, 1H), 3.06 (dd, J = 13.5, 6.0 Hz, 1H), 2.95 (dd, J = 13.5, 8.2 Hz, 1H), 2.45 
(dt, J = 17.7, 5.3 Hz, 1H), 2.28 (dddd, J = 17.7, 9.5, 3.4, 2.3 Hz, 1H); δC 166.3 (C), 140.4 (CH), 
136.3 (C), 133.5 (CH), 131.6 (CH), 129.0 (CH), 127.9 (CH), 124.9 (C), 124.7 (CH), 50.5 (CH), 
41.7 (CH2), 29.6 (CH2); LRMS (EI) m/z 171 [M
+
 (
81
Br)-C5H6NO, 3%], 169 (3), 97 (6), 96 (100), 95 
(12), 78 (12), 68 (10); HRMS (ESI): Calculated for C12H13
79
BrNO (M
+
+H) 266.0181, found 
266.0177.  
(S)-6-(2-Bromophenethyl)-5,6-dihydropyridin-2(1H)-one (12b): The representative procedure 
was followed by using acrylamide 11b (90 mg, 0.29 mmol). Purification by column 
chromatography (hexane/AcOEt, 3:2) yielded 12b (61 mg, 75%) as a white solid; mp 80-83 ºC 
(hexane/CH2Cl2); [α]D
23
 +26 (c 0.70, CH2Cl2); Rf 0.38 (AcOEt); IR ν (KBr) 3220, 1672, 1610, 
1470, 1422  cm
−1
;  δH 7.53 (d, J = 7.8 Hz, 1H), 7.24 (d, J = 4.1 Hz, 2H), 7.08 (dt, J = 8.0, 4.4 Hz, 
1H), 6.61 (ddd, J = 9.9, 5.2, 3.3 Hz, 1H), 6.44 (br s, 1H), 5.93 (ddd, J = 9.9, 3.5, 2.1 Hz, 1H), 3.72-
3.60 (m, 1H), 2.81 (ddd, J = 9.1, 6.9, 2.4 Hz, 2H), 2.46 (tt, J = 9.7, 4.9 Hz, 1H), 2.31-2.18 (m, 1H), 
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1.97-1.80 (m, 2H); δC 166.6 (C), 140.6 (CH), 140.3 (C), 133.0 (CH), 130.4 (CH), 128.1 (CH), 127.8 
(CH), 124.6 (CH), 124.4 (C), 50.6 (CH), 35.6 (CH2), 32.1 (CH2), 29.8 (CH2); LRMS (EI) m/z 200 
(M
+
-Br, 54%), 132 (10), 96 (100), 78 (10), 68 (11); HRMS (ESI): Calculated for C13H15
79
BrNO 
(M
+
+H) 280.0337, found 280.0330.  
(S)-6-[3-(2-Bromophenyl)propyl]-5,6-dihydropyridin-2(1H)-one (12c): The representative 
procedure was followed by using acrylamide 11c (129 mg, 0.40 mmol). Purification by column 
chromatography (hexane/AcOEt, 3:2) yielded 12c (96 mg, 81%) as a colorless oil; [α]D
23
 +33 (c 
0.77, CH2Cl2); Rf 0.47 (AcOEt); IR ν (film) 3221, 2933, 1672, 1610, 749  cm
−1
;  δH 7.52 (dd, J = 
8.0, 1.0 Hz, 1H), 7.26-7.18 (m, 2H), 7.06 (ddd, J = 7.9, 7.1, 2.1 Hz, 1H), 6.59 (ddd, J = 9.9, 5.3, 3.1 
Hz, 1H), 6.04 (br s, 1H), 5.93-5.87 (m, 1H), 3.67-3.58 (m, 1H), 2.80-2.72 (m, 2H), 2.40 (dt, J = 
17.7, 5.4 Hz, 1H), 2.20-2.10 (m, 1H), 1.74-1.55 (m, 4H); δC 166.6 (C), 141.0 (C), 140.7 (CH), 133.0 
(CH), 130.4 (CH), 127.9 (CH), 127.6 (CH), 124.6 (CH), 124.4 (C), 50.9 (CH), 35.9 (CH2), 35.0 
(CH2), 29.9 (CH2), 25.8 (CH2); LRMS (EI) m/z 294 (M
+
(
81
Br)-1, 2%), 292 (2), 267 (5), 265 (5), 214 
(26), 96 (100); HRMS (ESI): Calculated for C14H17
79
BrNO (M
+
+H) 294.0473, found 294.0482.  
 
General procedure for the synthesis of tricyclic compounds 13 from pyridine-2-ones 12:  
A mixture of the corresponding pyridine-2-one 12 (0.3 mmol), CuI (4.6 mg, 0.024 mmol), K2CO3 
(83 mg, 0.6 mmol) and N,N,N’,N’-tetrametiletilendiamina (5.6 mg, 7 µL, 0.048 mmol) in dry 
dioxane (0.75 mL) was stirred at 100 ºC under Ar for 20 h in a high-pressure tube. Then, the 
resulting mixture was cooled down to room temperature and hydrolyzed with H2O (5 mL), 
extracted with AcOEt (3 × 10 mL), dried over anhydrous MgSO4 and evaporated (15 Torr). The 
resulting residue was purified by column chromatography (silica gel, hexane/EtOAc) to yield pure 
products 13. Yields, physical and spectroscopic data follow. 
(R)-9a,10-Dihydropyrido[1,2-a]indol-6(9H)-one (13a): The representative procedure was 
followed by using pyridine-2-one 12a (112 mg, 0.42 mmol). Purification by column 
chromatography (hexane/AcOEt, 3:1) yielded 13a (70 mg, 90%) as a white solid; mp 93-96 ºC 
(hexane/CH2Cl2); [α]D
23
 +89 (c 1.00, CH2Cl2); Rf 0.41 (hexane/AcOEt, 1:1); IR ν (KBr) 1650, 
1587, 1478, 1416  cm
−1
;  δH 8.22 (d, J = 7.9 Hz, 1H), 7.26-7.19 (m, 2H), 7.03 (t, J = 7.5 Hz, 1H), 
6.68 (ddd, J = 9.8, 6.4, 2.0 Hz, 1H), 6.10 (dd, J = 9.9, 3.0 Hz, 1H), 4.26-4.16 (m, 1H), 3.29 (dd, J = 
15.5, 8.3 Hz, 1H), 2.88 (dd, J = 15.5, 10.9 Hz, 1H), 2.70 (dt, J = 17.63, 5.18 Hz, 1H), 2.45-2.34 (m, 
1H); δC 162.3 (C), 142.4 (C), 139.1 (CH), 129.7 (C), 127.8 (CH), 126.8 (CH), 124.6 (CH), 123.7 
(CH), 116.1 (CH), 57.8 (CH), 36.0 (CH2), 31.1 (CH2); LRMS (EI) m/z 185 (M
+
, 100%), 186 (13), 
156 (16), 118 (97), 117 (56), 90 (26), 89 (28), 68 (61), 63 (10); HRMS (ESI): Calculated for 
C12H12NO (M
+
+H) 186.0919, found 186.0912.  
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(S)-4,4a,5,6-Tetrahydro-1H-pyrido[1,2-a]quinolin-1-one (13b): The representative procedure 
was followed by using pyridine-2-one 12b (49 mg, 0.175 mmol). Purification by column 
chromatography (hexane/AcOEt, 3:1) yielded 13b (29 mg, 83%) as a white solid; mp 58-60 ºC 
(hexane/CH2Cl2); [α]D
23
 +83 (c 0.81, CH2Cl2); Rf 0.44 (hexane/AcOEt, 1:1); IR ν (KBr) 3045, 
2942, 1665, 1488, 1397, 1316 cm
−1
;  δH 8.06 (dd, J = 8.3, 0.8 Hz, 1H), 7.22-7.16 (m, 1H), 7.10-7.06 
(m, 1H), 6.99 (td, J = 7.4, 1.2 Hz, 1H), 6.70-6.65 (m, 1H), 6.08 (ddd, J = 9.7, 2.2, 1.4 Hz, 1H), 4.00-
3.92 (m, 1H), 2.82-2.68 (m, 2H), 2.49-2.36 (m, 2H), 2.05 (dq, J = 13.7, 4.6 Hz, 1H), 1.84 (dtd, J = 
13.1, 10.1, 4.9 Hz, 1H); δC 164.63 (C), 140.27 (CH), 136.91 (C), 130.20 (C), 128.27 (CH), 126.98 
(CH), 126.34 (CH), 124.06 (CH), 123.61 (CH), 56.48 (CH), 31.66 (CH2), 29.77 (CH2), 27.63 
(CH2); LRMS (EI) m/z 199 (M
+
, 100%), 200 (15), 170 (12), 132 (87), 131 (74), 130 (97), 103 (10), 
77 (14), 68 (12); HRMS (ESI): Calculated for C13H14NO (M
+
+H) 200.1075, found 200.1066.  
 
General procedure for the synthesis of 2-allylbenzo-fused heterocycles 14 from homoallyl 
amines 10:  
A mixture of the homoallyl amine 10 (0.5 mmol), Cs2CO3 (326 mg, 1.0 mmol), PPh3 (20 mg, 0.075 
mmol) and Pd(OAc)2 (5.6 mg, 0.025 mmol) in dry toluene (5 mL) was stirred at 110 ºC under Ar 
for 21 h in a high-pressure tube. Then, the resulting mixture was cooled down to room temperature, 
hydrolyzed with 3M HCl (5 mL, 15 mmol) and diluted with AcOEt (10 mL). The organic phase 
was extracted with 3M HCl (4 × 10 mL) and then all the aqueous phases were basified with NaOH 
until pH 13 and extracted with AcOEt (4 × 15 mL). The resulting organic phase was dried over 
anhydrous MgSO4 and evaporated (15 Torr). The residue was purified by column chromatography 
(silica gel, hexane/EtOAc) to yield pure products 14. Yields, physical and spectroscopic data 
follow. 
(R)-2-Allylindoline (14a): The representative procedure was followed by homoallyl amine 10a (96 
mg, 0.40 mmol). Purification by column chromatography (hexane/AcOEt, 10:1) yielded 14a (43 
mg, 68%) as a yellow oil; [α]D
23
 +14 (c 0.75, CH2Cl2); Rf 0.43 (hexane/AcOEt, 10:1); IR ν (film) 
3375, 2926, 1608, 1484, 1466, 1246, 914, 744 cm
−1
;  δH 7.07 (d, J = 7.3 Hz, 1H), 7.00 (t, J = 7.6 
Hz, 1H), 6.68 (td, J = 7.4, 1.0 Hz, 1H), 6.60 (d, J = 7.7 Hz, 1H), 5.90-5.75 (m, 1H), 5.17-5.06 (m, 
2H), 3.89 (dtd, J = 8.7, 7.2, 6.0 Hz, 1H), 3.14 (dd, J = 15.6, 8.7 Hz, 1H), 2.73 (dd, J = 15.6, 7.1 Hz, 
1H), 2.36-2.28 (m, 2H); δC 150.7 (C), 135.3 (CH), 128.6 (C), 127.4 (CH), 124.9 (CH), 118.7 (CH), 
117.6 (CH2), 109.3 (CH), 58.8 (CH), 41.1 (CH2), 35.8 (CH2); LRMS (EI) m/z 159 (M
+
, 12%), 118 
(100), 117 (17), 91 (14); HRMS (ESI): Calculated for C11H14N (M
+
+H) 160.1126, found 160.1126. 
(S)-2-Allyl-1,2,3,4-tetrahydroquinoline (14b): The representative procedure was followed by 
homoallyl amine 10b (127 mg, 0.50 mmol). Purification by column chromatography 
(hexane/AcOEt, 10:1) yielded 14b (77 mg, 89%) as a yellow oil; [α]D
23
 +48 (c 1.07, CH2Cl2); Rf 
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0.55 (hexane/AcOEt, 9:1); IR ν (film) 3398, 2921, 1483, 1309, 913 cm−1;  δH 6.97-6.91 (m, 2H), 
6.59 (td, J = 7.4, 1.1 Hz, 1H), 6.47-6.43 (m, 1H), 5.88-5.76 (m, 1H), 5.19-5.12 (m, 2H), 3.84 (br s, 
1H), 3.28 (dddd, J = 9.8, 8.0, 5.0, 2.9 Hz, 1H), 2.87-2.68 (m, 2H), 2.36-2.28 (m, 1H), 2.21-2.12 (m, 
1H), 1.95 (dddd, J = 12.5, 5.7, 3.7, 3.0 Hz, 1H), 1.63 (dddd, J = 12.8, 11.2, 9.8, 5.5 Hz, 1H); δC 
144.61 (C), 135.1 (CH), 129.3 (CH), 126.8 (CH), 121.3 (C), 118.0 (CH2), 117.1 (CH), 114.2 (CH), 
50.6 (CH), 41.3 (CH2), 28.3 (CH2), 26.5 (CH2); LRMS (EI) m/z. 173 (M
+
, 16%), 133 (12), 132 
(100), 130 (17), 117 (17); HRMS (ESI): Calculated for C12H16N (M
+
+H) 174.1283, found 
174.1280. 
(S)-2-Allyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine (14c): The representative procedure was 
followed by homoallyl amine 10c (134 mg, 0.50 mmol). Purification by column chromatography 
(hexane/AcOEt, 10:1) yielded 14c (79 mg, 84%) as a yellow oil; [α]D
23
 -19 (c 1.07, CH2Cl2); Rf 
0.61 (hexane/AcOEt, 9:1); IR ν (film) 3341, 2924, 1476, 1258, 737 cm−1;  δH 7.11-6.99 (m, 2H), 
6.83 (td, J = 7.4, 1.2 Hz, 1H), 6.70 (dd, J = 7.7, 1.1 Hz, 1H), 5.83 (dddd, J = 16.2, 11.0, 8.8, 5.3 Hz, 
1H), 5.27-5.12 (m, 2H), 3.70 (br s, 1H), 2.86-2.64 (m, 3H), 2.40-2.13 (m, 2H), 2.02-1.81 (m, 2H), 
1.66-1.42 (m, 2H); δC 148.9 (C), 135.9 (CH), 134.2 (C), 130.6 (CH), 126.7 (CH), 121.2 (CH), 119.9 
(CH), 118.4 (CH2), 57.0 (CH), 42.1 (CH2), 38.1 (CH2), 35.6 (CH2), 26.4 (CH2); LRMS (EI) m/z 187 
(M
+
, 9%), 147 (11), 146 (100), 131 (12), 130 (13), 118 (18); HRMS (ESI): Calculated for C13H18N 
(M
+
+H) 188.1439, found 188.1433.  
 
General procedure for the synthesis of acrylamides 15 from heterocycles 14:  
To a solution of the corresponding heterocyle 14 (1.25 mmol) and Et3N (171 mg, 0.24 mL, 1.7 
mmol)  in dry CH2Cl2 (3 mL) was added dropwise acryloyl chloride (159 g, 0.15 mL, 1.76 mmol) at 
0 ºC. The reaction mixture was stirred at room temperature for 2 h and after that it was hydrolyzed 
with H2O (5 mL) and diluted with AcOEt (15 mL). The aqueous phase was extracted with AcOEt (3 
× 10 mL). Then, the organic phases were dried with anhydrous MgSO4 and evaporated (15 Torr). 
The residue was purified by column chromatography (silica gel, hexane/AcOEt) to yield products 
15. Yields, physical and spectroscopic data follow. 
(S)-N-Acryloyl-2-allyl-1,2,3,4-tetrahydroquinoline (15b): The representative procedure was 
followed by heterocycle 14b (77 mg, 0.44 mmol). Purification by column chromatography 
(hexane/AcOEt, 10:1) yielded 15b (63 mg, 63%) as a colorless oil; [α]D
23
 -389 (c 1.03, CH2Cl2); Rf 
0.30 (hexane/AcOEt, 6:1); IR ν (film) 2947, 1651, 1651, 1614, 1489, 1404, 1323, 1241, 914, 750 
cm
−1
;  δH 7.22-7.13 (m, 3H), 7.02 (d, J = 7.1 Hz, 1H), 6.42 (s, 1H), 6.41 (d, J = 0.8 Hz, 1H), 5.81-
5.69 (m, 1H), 5.65-5.59 (m, 1H), 5.00 (s, J = 1.1 Hz, 1H), 4.98-4.94 (m, 1H), 4.93-4.84 (m, 1H), 
2.66 (dt, J = 15.1, 5.4 Hz, 1H), 2.56 (ddd, J = 15.2, 10.1, 5.5 Hz, 1H), 2.42-2.25 (m, 2H), 2.20-2.11 
(m, 1H), 1.54 (dddd, J = 12.8, 10.1, 6.9, 5.6 Hz, 1H); δC 165.4 (C), 137.2 (C), 134.4 (CH), 129.8 
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(CH), 127.8 (CH), 127.7 (CH2), 126.4 (CH), 126.3 (CH), 125.9 (CH), 117.4 (CH2), 51.7 (CH), 38.9 
(CH2), 29.7 (CH2), 25.7 (CH2); LRMS (EI) m/z 186 (M
+
-C3H5, 46%), 133 (11), 132 (100), 130 (10), 
55 (16); HRMS (ESI): Calculated for C15H18NO (M
+
+H) 228.1388, found 228.1383. 
 (S)-N-Acryloyl-2-allyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine (15c): The representative 
procedure was followed by homoallyl amine 14c (180 mg, 0.96 mmol). Purification by column 
chromatography (hexane/AcOEt, 10:1) yielded 15c (122 mg, 52%) as a yellow oil; [α]D
23
 -179 (c 
1.09, CH2Cl2); Rf 0.28 (hexane/AcOEt, 6:1); IR ν (film) 2928, 1653, 1490, 1405, 1254 cm
−1
;  δH 
7.31-7.18 (m, 3H), 7.02 (d, J = 6.8 Hz, 1H), 6.36 (dd, J = 16.8, 2.1 Hz, 1H), 5.94 (dd, J = 16.8, 10.3 
Hz, 1H), 5.74 (ddt, J = 17.1, 10.3, 6.8 Hz, 1H), 5.48 (dd, J = 10.3, 2.1 Hz, 1H), 5.06-4.93 (m, 3H), 
2.81-2.72 (m, 1H), 2.65 (dt, J = 14.2, 4.5 Hz, 1H), 2.15-2.03 (m, 1H), 1.99-1.86 (m, 2H), 1.84-1.72 
(m, 1H), 1.65-1.51 (m, 2H); δC 165.3 (C), 140.4 (C), 138.3 (C), 135.2 (CH), 130.4 (CH), 129.8 
(CH), 129.1 (CH), 128.4 (CH), 127.5 (CH2), 126.8 (CH), 117.0 (CH2), 51.3 (CH), 36.1 (CH2), 33.3 
(CH2), 31.1 (CH2), 21.2 (CH2); LRMS (EI) m/z 241 (M
+
, 3%), 201 (10), 200 (66), 147 (13), 146 
(100), 55 (14); HRMS (ESI): Calculated for C16H20NO (M
+
+H) 242.1545, found 242.1544.  
 
General procedure for the synthesis of tricyclic compounds 13 from acrylamides 15:  
A mixture of the corresponding acrylamide 15 (0.50 mmol), ruthenium Hoveyda-Grubbs catalyst 
(12.6 mg, 0.015 mmol) in dry CH2Cl2 (5 mL) was stirred under Ar at 40 ºC for 3 h. Then the 
solvent was evaporated (15 Torr) and the resulting residue was purified by column chromatography 
(silica gel, hexane/AcOEt) to yield products 13. Yields, physical and spectroscopic data follow. 
(S)-4,4a,5,6-Tetrahydro-1H-pyrido[1,2-a]quinolin-1-one (13b): The representative procedure 
was followed by using acrylamide 15b (58 mg, 0.25 mmol). Purification by column 
chromatography (hexane/AcOEt, 3:1) yielded 13b (42 mg, 83%) as a white solid. 
(S)-4a,5,6,7-Tetrahydrobenzo[f]pyrido[1,2-a]azepin-1(4H)-one (13c): The representative 
procedure was followed by homoallyl amine 15c (87 mg, 0.36 mmol). Purification by column 
chromatography (hexane/AcOEt, 10:1) yielded 13c (60 mg, 79%) as a white solid; mp 130-132 ºC 
(hexane/CH2Cl2); [α]D
23
 -118 (c 1.03, CH2Cl2); Rf 0.30 (hexane/AcOEt, 1:2); IR ν (KBr) 1657, 
1614, 1595, 1434, 1426 cm
−1
;  δH 7.28-7.17 (m, 4H), 6.59 (dddd, J = 9.8, 6.2, 2.4, 1.3 Hz, 1H), 6.06 
(ddd, J = 9.9, 3.0, 0.6 Hz, 1H), 3.63-3.54 (m, 1H), 2.92 (ddt, J = 18.0, 7.2, 2.7 Hz, 1H), 2.80 (ddd, J 
= 14.2, 11.9, 2.3 Hz, 1H), 2.69 (ddd, J = 14.2, 6.2, 2.2 Hz, 1H), 2.34-2.16 (m, 2H), 2.08-1.95 (m, 
1H), 1.68-1.58 (m, 1H), 1.58-1.41 (m, 1H); δC 163.0 (C), 142.0 (C), 139.7 (C), 138.6 (CH), 130.1 
(CH), 128.5 (CH), 127.7 (CH), 127.1 (CH), 125.0 (CH), 57.9 (CH), 34.9 (CH2), 33.8 (CH2), 31.0 
(CH2), 26.1 (CH2); LRMS (EI) m/z 213 (M
+
, 85%), 214 (13), 212 (25), 196 (10), 184 (11), 146 (21), 
145 (100), 144 (28), 130 (17), 118 (30), 117 (46), 115 (10), 91 (11), 90 (18), 89 (15), 68 (15); 
HRMS (ESI): Calculated for C14H16NO (M
+
+H) 214.1232, found 214.1225.  
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 Synthesis of (S)-2-allyl-N-methtyl-1,2,3,4-tetrahydroquinoline (16): A mixture of the 2-
allyltetrahydroquinoline 14b (123 mg, 0.71 mmol), paraformaldehyde (95 mg, 3.2 mmol), 
NaBH3CN (133 mg, 2.1 mmol) and acetic acid (126 mg, 0.120 mL, 2.1 mmol) in acetonitrile (6 
mL) was stirred at 23 ºC for 16 h. Then, the resulting mixture was hydrolyzed with 3M HCl (5 mL, 
15 mmol) and diluted with AcOEt (10 mL). The organic phase was extracted with 3M HCl (4 × 10 
mL) and then all the aqueous phases were basified with NaOH until pH 13 and extracted with 
AcOEt (4 × 15 mL). The resulting organic phase was dried over anhydrous MgSO4 and evaporated 
(15 Torr) to give 126 mg (0.67 mmol, 95%) of pure compound 16. Physical and spectroscopic data 
follow: Yellow wax; [α]D
23
 -9 (c 1.27, CH2Cl2); Rf 0.72 (hexane/AcOEt, 9:1); IR ν (film) 2929, 
1602, 1497, 1332, 1213, 911 cm
−1
;  δH 7.08 (t, J = 7.8 Hz, 1H), 6.97 (d, J = 7.3 Hz, 1H), 6.59 (td, J 
= 7.3, 1.1 Hz, 1H), 6.53 (d, J = 8.2 Hz, 1H), 5.79 (dddd, J = 16.8, 10.3, 8.1, 6.4 Hz, 1H), 5.12-5.03 
(m, 2H), 3.37-3.27 (m, 1H), 2.93 (s, 3H), 2.89-2.74 (m, 1H), 2.70-2.60 (m, 1H), 2.47-2.36 (m, 1H), 
2.21-2.08 (m, 1H), 1.97-1.79 (m, 2H); δC 145.3 (C), 135.6 (CH), 128.8 (CH), 127.2 (CH), 121.9 
(C), 117.2 (CH2), 115.6 (CH), 110.6 (CH), 58.8 (CH), 38.0 (CH3), 36.0 (CH2), 24.4 (CH2), 23.5 
(CH2); LRMS (EI) m/z 187 (M
+
, 12%), 147 (11), 146 (100), 144 (11), 131 (17), 130 (15); HRMS 
(ESI): Calculated for C13H18N (M
+
+H) 188.1439, found 188.1445. 
 
Synthesis of (-)-angustureine (18) from (S)-2-allyl-N-methtyl-1,2,3,4-tetrahydroquinoline (16): 
A mixture of 2-allyl-N-methyltetrahydroquinoline 16 (93 mg, 0.50 mmol), cis-3-hexene (86 mg, 
0.127 mL, 1.0 mmol) and ruthenium Hoveyda-Grubbs catalyst (12.7 mg, 0.015 mmol) in dry 
CH2Cl2 (6 mL) was stirred under Ar at 40 ºC for 3 h. Then the solvent was evaporated (15 Torr), the 
resulting residue was dissolved in MeOH (9 mL) and Pd/C 10% (27 mg, 0.015 mmol) was added. 
The resulting reaction mixture was stirred for 12 h at 23 ºC under H2 (1 atm), then filtered through 
celite and evaporated (15 Torr).  The resulting residue was purified by column chromatography 
(silica gel, hexane/AcOEt: 20/1) to yield 59 mg (0.27 mmol, 54%) of pure (-)-angustureine (18).
31
 
Physical and spectroscopic data follow: colorless oil; [α]D
23
 -6.8 (c 1.00, CH2Cl2); Rf 0.18 
(hexane/AcOEt, 20:1); IR ν (film) 2926, 1602, 1498, 741 cm−1;  δH 7.06 (t, J = 7.7 Hz, 1H), 6.95 (d, 
J = 7.3 Hz, 1H), 6.57 (td, J = 7.3, 1.0 Hz, 1H), 6.51 (d, J = 8.2 Hz, 1H), 3.21 (dq, J = 8.5, 4.2 Hz, 
1H), 2.91 (s, 3H), 2.84-2.73 (m, 1H), 2.64 (dt, J = 16.2, 4.2 Hz, 1H), 1.92-1.83 (m, 2H), 1.64-1.53 
(m, 1H), 1.45-1.20 (m, 8H), 0.89 (t, J = 6.9 Hz, 3H); δC 145.5 (C), 128.7 (CH), 127.2 (CH), 122.0 
(C), 115.3 (CH), 110.5 (CH), 59.1 (CH), 38.1 (CH3), 32.2 (CH2), 31.4 (CH2), 25.9 (CH2), 24.6 
(CH2), 23.7 (CH2), 22.8 (CH2), 14.2 (CH3); LRMS (EI) m/z 217 (M
+
, 14%), 147 (11), 147 (11), 146 
(100), 144 (8). 
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Synthesis of (S,E)-2-[3-(3,4-Dimethoxyphenyl)allyl]-1-methyl-1,2,3,4-tetrahydroquinoline (19): 
A mixture of 2-allyl-N-methyltetrahydroquinoline 16 (51 mg, 0.27 mmol), 4-bromoveratrol (148 
mg, 0.100 mL, 0.68 mmol), K2CO3 (75 mg, 0.54 mmol) and Pd(PPh3)4 (15.6 mg, 0.0135 mmol) in dry 
dioxane (1 mL) was stirred at 100 ºC under Ar for 24 h in a high-pressure tube. Then, the resulting 
mixture was cooled down to room temperature, diluted with AcOEt (10 mL), filtered through a 
short pad of Celite and concentrated in vacuo (15 Torr). The residue was purified by column 
chromatography (silica gel, hexane/AcOEt: 17/1) to yield 35 mg (0.11 mmol, 40%) of pure 
compound 19. Physical and spectroscopic data follow: yellow oil; [α]D
23
 -29 (c 1.10, CH2Cl2); Rf 
0.53 (hexane/AcOEt, 3:1); IR ν (film) 2931, 1601, 1511, 1498, 1260 cm−1;  δH 7.09 (t, J = 7.7 Hz, 
1H), 6.99 (d, J = 7.1 Hz, 1H), 6.90-6.85 (m, 2H), 6.81 (d, J = 8.8 Hz, 1H), 6.61 (t, J = 7.3 Hz, 1H), 
6.55 (d, J = 8.1 Hz, 1H), 6.36 (d, J = 15.7 Hz, 1H), 6.05 (ddd, J = 15.0, 8.0, 6.8 Hz, 1H), 3.90 (s, 
3H), 3.87 (s, 3H), 3.41 (td, J = 8.4, 4.3 Hz, 1H), 2.97 (s, 3H), 2.93-2.81 (m, 1H), 2.73-2.63 (m, 1H), 
2.59-2.49 (m, 1H), 2.29 (dt, J = 14.0, 8.6 Hz, 1H), 2.02-1.86 (m, 2H); δC 149.2 (C), 148.6 (C), 
145.3 (C), 132.0 (CH), 130.8 (C), 128.9 (CH), 127.3 (CH), 125.3 (CH), 121. 9 (C), 119.0 (CH), 
115.7 (CH), 111.3 (CH), 110.6 (CH), 108.7 (CH), 59.2 (CH3), 56.1 (CH3), 56.0 (CH3), 38.1 (CH), 
35.2 (CH2), 24.7 (CH2), 23.6 (CH2); LRMS (EI) m/z 323 (M
+
, 39%), 203 (10), 172 (25), 147 (12), 
146 (100), 144 (19), 131 (16), 130 (15), 120 (29), 91 (10); HRMS (ESI): Calculated for C21H26NO2 
(M
+
+H) 324.1964, found 324.1974. 
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